Short answer

Teleflex Inc (TFX) filed its fiscal 2013 10-K annual report with the SEC on Feb 24, 2014.

Top risk flagged: FDA medical-device regulation: 510(k)/PMA delays, recalls, fines or manufacturing shutdowns for noncompliance

Teleflex Inc FY2013 10-K analysis

AI summary of each section, grounded in the filing text

Medical technology model: single-use devices for critical care and surgery, sold through direct sales and distributors in more than 150 countries
2013 portfolio expansion: Vidacare, Ultimate Medical and Eon Surgical acquisitions, plus 27 new products and line extensions
New offerings: ARROW VPS G4, Cuff Pilot airways, AutoFuser pain pump, ISO-Gard Mask and microlaparoscopic surgical platform
Critical Care reached 70% of net revenues, with product-group revenue rising to $1,182.7 million from $1,040.3 million
R&D spending increased to $65.0 million from $56.3 million, while employees totaled approximately 11,400 globally
Distinctive transition: microlaparoscopic technology expected to generate revenues in late 2014, extending Teleflex into scarless surgery

Revenue $1,696.3M, up 9.4% YoY from $1,551.0M, driven by acquisitions adding $121.1M
Gross margin 49.5% vs 48.2%; SG&A margin 29.6% vs 29.3%
Best segment: Asia revenue $207.2M, up 19.3%; worst: OEM revenue $131.2M, down 6.5%
Operating cash flow $229.9M; capex $63.6M; dividends $55.9M; acquisitions $309.0M
Outlook: $15M-$20M LMA savings by 2014; risks from European receivables and healthcare pricing pressures

FDA medical-device regulation: 510(k)/PMA delays, recalls, fines or manufacturing shutdowns for noncompliance
European receivables exposure: $97.9 million in Italy, Spain, Portugal and Greece, with 260-day average collection periods
Manufacturing concentration: key products produced or distributed from single locations with limited alternate facilities
Healthcare reform: 2.3% medical-device excise tax, costing Teleflex $11.5 million in 2013
Leverage and conversion risk: $1,286 million debt and $400 million convertible notes currently classified as current liability

Generated from the filing text; verify against the original. How to read a 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.